Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8134813 | 8110950 | F | 8134813-X | 20110807 | 20120131 | 20120214 | EXP | JP-UCBSA-039315 | UCB | 58 | YR | F | Y | 20120214 | MD | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8134813 | 1018854320 | SS | CERTOLIZUMAB PEGOL | 2 | SUBCUTANEOUS | RA0006: 10/NOV/2009-UNKNOWN:400MG/2 WEEKS;UNKNOWN TO 13/MAY/2010-200MG/2WEEKS | |||||
| 8134813 | 1018854335 | C | EPERISONE HYDROCHLORIDE | 2 | TOTAL DAILY DOSE : 150 MG | ||||||
| 8134813 | 1018854338 | C | BLOCK INJECTION | 2 | PRN | ||||||
| 8134813 | 1018854318 | PS | CERTOLIZUMAB PEGOL | 2 | SUBCUTANEOUS | ||||||
| 8134813 | 1018854321 | C | FAMOTIDINE | 1 | TOTAL DAILY DOSE: 40 MG | ||||||
| 8134813 | 1018854328 | C | KETOPROFEN | 1 | ADEQUATE DOSE, PRN. | ||||||
| 8134813 | 1018854324 | C | ACTARIT | 2 | TOTAL DAILY DOSE : 300 MG | ||||||
| 8134813 | 1018854326 | C | NILVADIPINE | 2 | DAILY DOSE: 4 MG | ||||||
| 8134813 | 1018854327 | C | CELECOXIB | 1 | TOTAL DAILY DOSE : 400 MG | ||||||
| 8134813 | 1018854329 | C | KETOPROFEN | 1 | DAILY DOSE:50MG | ||||||
| 8134813 | 1018854330 | C | BUCILLAMINE | 2 | TOTAL DAILY DOSE : 200 MG | ||||||
| 8134813 | 1018854332 | C | LOXOPROFEN SODIUM HYDRATE | 2 | TOTAL DAILY DOSE : 180 MG | ||||||
| 8134813 | 1018854334 | C | LOXOPROFEN SODIUM HYDRATE | 2 | DAILY DOSE: 60MG | ||||||
| 8134813 | 1018854331 | C | BUCILLAMINE | 2 | DAILY DOSE: 200 MG | ||||||
| 8134813 | 1018854336 | C | MECOBALAMIN | 2 | TOTAL DAILY DOSE : 1500 MCG | ||||||
| 8134813 | 1018854322 | C | FAMOTIDINE | 1 | TOTAL DAILY DOSE : 40 MG | ||||||
| 8134813 | 1018854337 | C | DICLOFENAC SODIUM | 1 | DAILY DOSE : 50 MG, PRN | ||||||
| 8134813 | 1018854319 | SS | CERTOLIZUMAB PEGOL | 2 | SUBCUTANEOUS | ||||||
| 8134813 | 1018854323 | C | VALSARTAN | 1 | TOTAL DAILY DOSE: 80 MG | ||||||
| 8134813 | 1018854325 | C | NILVADIPINE | 2 | TOTAL DAILY DOSE : 4 MG | ||||||
| 8134813 | 1018854333 | C | LOXOPROFEN SODIUM HYDRATE | 2 | TOTAL DAILY DOSE : 120 MG |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8134813 | 1018854318 | RHEUMATOID ARTHRITIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8134813 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 8134813 | INFECTIOUS PLEURAL EFFUSION |
| 8134813 | PSOAS ABSCESS |
| 8134813 | PERICARDITIS |
| 8134813 | ARTHRITIS BACTERIAL |
| 8134813 | STAPHYLOCOCCAL SEPSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8134813 | 1018854320 | 20091110 | 20100513 | ||
| 8134813 | 1018854335 | 20110808 | 20110813 | ||
| 8134813 | 1018854338 | 20110808 | |||
| 8134813 | 1018854318 | 20110520 | 20110802 | ||
| 8134813 | 1018854321 | 20100401 | 20110813 | ||
| 8134813 | 1018854328 | 20101014 | |||
| 8134813 | 1018854326 | 20111029 | |||
| 8134813 | 1018854327 | 20101108 | 20110813 | ||
| 8134813 | 1018854329 | 20110808 | 20110812 | ||
| 8134813 | 1018854330 | 20110723 | 20110813 | ||
| 8134813 | 1018854332 | 20110808 | 20110813 | ||
| 8134813 | 1018854334 | 20110913 | |||
| 8134813 | 1018854331 | 20111115 | |||
| 8134813 | 1018854336 | 20110808 | 20110813 | ||
| 8134813 | 1018854322 | 20110822 | |||
| 8134813 | 1018854337 | 20110813 | 20110813 | ||
| 8134813 | 1018854319 | 20100525 | 20110422 | ||
| 8134813 | 1018854323 | 20021126 | 20110813 | ||
| 8134813 | 1018854325 | 20100803 | 20110813 | ||
| 8134813 | 1018854333 | 20110822 | 20110912 |